Pivotal role of nitrogen heterocycles in Alzheimer's disease drug discovery

S Kumari, K Maddeboina, RD Bachu, SHS Boddu… - Drug Discovery …, 2022 - Elsevier
Alzheimer's disease (AD) is a detrimental neurodegenerative disease that progressively
worsens with time. Clinical options are limited and only provide symptomatic relief to AD …

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19

DM Teli, MB Shah, MT Chhabria - Frontiers in molecular biosciences, 2021 - frontiersin.org
Historically, plants have been sought after as bio-factories for the production of diverse
chemical compounds that offer a multitude of possibilities to cure diseases. To combat the …

Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy

H Zhang, Y Peng, L Zhuo, Y Wang, G Zeng… - European Journal of …, 2022 - Elsevier
Due to the hugely important roles of neurotransmitter acetylcholine (ACh) and amyloid-β
(Aβ) in the pathogenesis of Alzheimer's disease (AD), the development of multi-target …

Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase …

X Lu, Y Li, Q Guan, H Yang, Y Liu, C Du… - ACS Chemical …, 2024 - ACS Publications
For the potential therapy of Alzheimer's disease (AD), butyrylcholinesterase (BChE) has
gradually gained worldwide interest in the progression of AD. This study used a …

Novel alkyl-substituted 4-methoxy benzaldehyde thiosemicarbazones: Multi-target directed ligands for the treatment of Alzheimer's disease

M Varma, V Ugale, J Shaukat, M Hollmann… - European Journal of …, 2023 - Elsevier
Alzheimer's disease (AD) is a devastating neurodegenerative disorder affecting mental
ability and interrupts neurocognitive functions. Treating multifactorial conditions of AD with a …

Novel coumarin–pyridine hybrids as potent multi-target directed ligands aiming at symptoms of Alzheimer's disease

E Babaei, TT Küçükkılınç, L Jalili-Baleh, H Nadri… - Frontiers in …, 2022 - frontiersin.org
In this research, a series of coumarin-based scaffolds linked to pyridine derivatives via a
flexible aliphatic linkage were synthesized and assessed as multifunctional anti-AD agents …

Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach

S Kumar, A Mahajan, R Ambatwar… - Current Medicinal …, 2024 - ingentaconnect.com
Alzheimer's disease (AD) is a neurodegenerative disease and one of the leading causes of
progressive dementia, affecting 50 million people worldwide. Many pathogenic processes …

Recent advances towards diagnosis and therapeutic fingerprinting for Alzheimer's disease

LK Pradhan, PK Sahoo, S Chauhan, SK Das - Journal of Molecular …, 2022 - Springer
Since the report of “a peculiar severe disease process of the cerebral cortex” by Alois
Alzheimer in 1906, it was considered to be a rare condition characterized by loss of …

Carbazole-based semicarbazones and hydrazones as multifunctional anti-Alzheimer agents

KB Patel, DV Patel, NR Patel, AM Kanhed… - Journal of …, 2022 - Taylor & Francis
With the aim to combat a multi-faceted neurodegenerative Alzheimer's disease (AD), a
series of carbazole-based semicarbazide and hydrazide derivatives were designed …

Challenges and discoveries in polypharmacology of neurodegenerative diseases

TCM Lustoza Rodrigues, NF de Sousa… - Current Topics in …, 2023 - ingentaconnect.com
Background: Neurological disorders are composed of several diseases that affect the central
and peripheral nervous system; among these are neurodegenerative diseases, which lead …